Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEMIPLIMAB vs CERTOLIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEMIPLIMAB vs CERTOLIZUMAB: Safety Overview

Metric CEMIPLIMAB CERTOLIZUMAB
Total FAERS Reports 1,020 531
Deaths Reported 175 32
Death Rate 17.2% 6.0%
Hospitalizations 651 164
Average Patient Age 68.9 yrs 54.0 yrs
% Female Patients 36.6% 74.8%
Manufacturer Regeneron Pharmaceuticals, Inc. N/A
Route INTRAVENOUS N/A